Trials / Completed
CompletedNCT02877615
Efficacy and Safety Trial With S 44819 After Recent Ischemic Cerebral Event
Randomized Efficacy and Safety Trial With Oral S 44819 After Recent Ischemic Cerebral Event. International, Multi-centre, Randomized, Doubleblind Placebo-controlled Phase II Study. (RESTORE BRAIN Study)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 585 (actual)
- Sponsor
- Institut de Recherches Internationales Servier · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the efficacy and safety of S 44819 in enhancing functional recovery after an ischemic stroke.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | S 44819 150 mg twice a day | One sachet of S 44819 150 mg and one sachet of placebo twice a day |
| DRUG | S 44819 300 mg twice a day | Two sachets of S 44819 150 mg twice a day |
| DRUG | Placebo | Two sachets of placebo twice a day |
Timeline
- Start date
- 2016-12-19
- Primary completion
- 2019-03-10
- Completion
- 2019-03-10
- First posted
- 2016-08-24
- Last updated
- 2020-03-11
Locations
121 sites across 15 countries: Australia, Belgium, Brazil, Canada, Czechia, France, Germany, Hungary, Italy, Netherlands, Poland, South Korea, Spain, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT02877615. Inclusion in this directory is not an endorsement.